TrialHaematologica2023

IELSG40/CLEO phase II trial of clarithromycin and lenalidomide in relapsed/refractory extranodal marginal zone lymphoma.

Maria Cristina Pirosa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.